Medicaid Prescription Formulary Restrictions and Arthritis Treatment Costs
AUTOR(ES)
Johnson, Tricia J.
FONTE
American Public Health Association
RESUMO
Objectives. We used the Arizona Medicaid program as a model to examine the consequences of the relative restrictiveness of nonsteroidal anti-inflammatory drug (NSAID)–preferred drug lists on health care use and costs for Medicaid enrollees with arthritis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2424082Documentos Relacionados
- Physicians' liability and drug formulary restrictions
- Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?
- Nursing home costs, Medicaid rates, and profits under alternative Medicaid payment systems.
- Canadian prescription drug costs surpass $18 billion
- Effect of dietary restrictions on disease activity in rheumatoid arthritis.
